Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2-Reference-Cited by-同舟云学术

Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2

Published:2020-01 Issue: Volume:95 Page:103461
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Alkahtani Hamad M.,Abdalla Ashraf N.,Obaidullah Ahmad J.,Alanazi Mohammed M.,Almehizia Abdulrahman A.,Alanazi Mashael G.,Ahmed Ahmed Y.,Alwassil Osama I.,Darwish Hany W.,Abdel-Aziz Alaa A.-M.,El-Azab Adel S.

Funder

NIH

National Plan for Science, Technology and Innovation

Deanship of Scientific Research at King Saud University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference60 articles.

1. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers;Roskoski;Pharmacol. Res.,2019

2. Targeting the HER/EGFR/ErbB family to prevent breast cancer;Howe;Cancer Prev. Res. (Phila),2011

3. Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib;Efferth;Phytomedicine,2017